Cross Keys Capital Advises New Jersey Cancer Care, PA, in Its Partnership with Regional Cancer Care Associates
July 02 2024 - 8:00AM
Cross Keys Capital, LLC, a leading independent investment banking
firm providing M&A advisory services to physician group
practices and healthcare services companies, is pleased to announce
it acted as the exclusive financial advisor to New Jersey Cancer
Care, PA, (NJCC) in its partnership with Regional Cancer Care
Associates (RCCA), a strategic partner of The US Oncology Network.
NJCC consists of eight medical oncologists and eleven total
providers operating across three offices in the North Jersey
market. NJCC is one of the largest independent medical oncology
groups in New Jersey and is led by Dr. James Orsini, Sr. NJCC has
served the North Jersey marketplace since its founding in 1998 and
continues to be a leader in community-based cancer care within the
region. The partnership between NJCC and RCCA will bolster NJCC’s
existing footprint in the region through access to RCCA’s vast
clinical and administrative resources.
As part of the transaction, NJCC will join RCCA’s existing
network of 94 physicians and 77 advanced practice providers located
throughout their 22 clinics in New Jersey, Maryland, and
Connecticut.
“We worked closely with Cross Keys Capital throughout the entire
process to evaluate the market and find a partner in the region
with the infrastructure and vision to help us take the practice to
the next level,” said Dr. James Orsini, Sr. “This was a complex
transaction, and I am thankful to have had the Cross Keys team by
my side each step of the way to provide both guidance and solutions
on navigating the process. Community-based oncology is changing
rapidly and having an advisor like Cross Keys who understands those
dynamics was invaluable, not only for finding us the right “fit” in
terms of a partner, but also for ensuring the deal stayed on track
from start to finish.”
When asked about the transaction, Bill Britton, Co-Founder and
Managing Director of Cross Keys Capital said, “We are extremely
pleased to announce the partnership between New Jersey Cancer Care
and Regional Cancer Care Associates. After representing RCCA last
year in their strategic partnership with The US Oncology Network,
it’s great for Cross Keys to continue our involvement in the
medical oncology space and cement ourselves as the go-to investment
bank for independent oncology groups. This transaction will be very
beneficial for New Jersey Cancer Care since both RCCA and The US
Oncology Network have immense resources to bring to bear for our
client. It was a pleasure to work with Dr. Orsini and his team, and
we are excited to see what the future holds for his practice, as
well as RCCA.”
Cross Keys Capital’s deal team consisted of Bill Britton and Roy
Barnes.
Brach Eichler, LLP, led by Joseph Gorrell, provided legal
counsel to NJCC.
About Cross Keys CapitalCross Keys Capital is a
leading middle-market investment bank providing a full range of
investment banking merger and acquisition advisory services to
businesses in the healthcare services, niche manufacturing,
aerospace/defense, business services, specialty contracting,
consumer products, distribution, and logistics sectors.
Cross Keys Capital’s healthcare services team is nationally
recognized as a leader in providing merger and acquisition advisory
services to independent physician group practices and healthcare
services companies. To date, the firm’s healthcare practice has
completed the sale or merger of over 200 transactions including
independent physician group practices, healthcare services
providers, and healthcare technology companies. For more
information on Cross Keys Capital or to discuss a contemplated
partnership or sale, please contact Bill Britton, Co-Founder and
Managing Director, at 954-410-1936 or bbritton@ckcap.com, or please
visit our website at www.ckcap.com.